Therapeutic approach to treat virus-induced lung failure for severe COVID-19 shows promise in clinical trial
A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery ...
Scientists Develop Breakthrough Nasal Spray That Could Delay Alzheimer’s by Over a Decade
Research from the College of Medicine provides promising insights into delaying the progression of Alzheimer’s disease for ...
healthday1h
FDA Approves Cobenfy for Adults With Schizophrenia
THURSDAY, Nov. 14, 2024 (HealthDay News) -- The U.S. Food and Drug Administration has approved Cobenfy (xanomeline and ...